Michael Swanick, global leader of PwC's pharmaceutical and life sciences practice, shares findings based on our Health Research Institute's annual Top health industry issues report.
Each fall, PwC’s Health Research Institute (HRI) polls 1,000 consumers and interviews industry experts to identify the top ten health industry issues for the coming year. The scope of the survey ranges across the entire healthcare landscape, from manufacturers to providers to insurers and retailers.
4 of the 10 findings that we believe will directly impact pharma, biotech and device manufacturers are:
PwC’s Pharmaceutical and life sciences works with you from strategy through execution. Discover other ways we’ll help you succeed in the New Health Economy.